Peter Dudek
InvestorPresident and Managing Partner at MRL Ventures Fund · Board director at Ambagon Therapeutics · Board director at Xilio Therapeutics
Cambridge, Massachusetts
Find your path to Peter
505 people in our graph share verified history with Peter — schools, employers, funds. One of them is your warm intro.
Dan LynchunlockedPeter: together at Xilio Therapeutics (2020–2021)
×4Peter: together at University of Oxford
Peter: together at University of Geneva
Peter: together at Kymera Therapeutics
About
Ph.D. and president and managing partner of MRL Ventures Fund, describing the fund as an institutional venture partner taking active board or observer roles.
Contact· published on Peter's own website
Board director at Ambagon Therapeutics
Intro paths
→
In turn, Peter can intro founders to Ambagon Therapeutics's investors below.
Ambagon Therapeutics's investors · 7
Droia VenturesLuxembourg · $540K checks · since 2021InkefAmsterdam · since 2025Mission BiocapitalSan Francisco · $500K checks · since 2025MRL Ventures FundCambridge · $25M checks · since 2025Nextech InvestZurich · $648K – $3.2M checks · since 2025RA CapitalBoston · since 2025SynconaLondon · since 2022
Co-founders at Ambagon Therapeutics
CO
Christian OttmannExecutive Officer
Board director at Xilio Therapeutics
Intro paths
→
In turn, Peter can intro founders to Xilio Therapeutics's investors below.
Xilio Therapeutics's investors · 16
AbingworthLondon · $15M – $30M checks · since 2020Atlas VentureCambridge · $500K – $1M checks · since 2021Bain Capitalsince 2021Bain Capital Life SciencesBoston · since 2021Bay City CapitalSan Rafael · $5M – $10M checksDeerfield Management CompanyNew YorkF-Prime CapitalCambridge · $3M – $10M checks · since 2021M VenturesLos Angeles · $10.8M checks · since 2020MRL Ventures FundCambridge · $25M checksRA CapitalBostonRiverVest Venture PartnersSt. Louis · $500K – $3M checksRock Springs CapitalBaltimoreSolasta VenturesBostonSV Health InvestorsBoston · $1M – $20M checks · since 2018SV7 Impact MedicineLondonTakeda VenturesCambridge · $1M – $5M checks
Co-founders at Xilio Therapeutics
RR
René RussoExecutive Officer, Director
Experience
- MerckPresident & Managing Partner, MRL Ventures Fundcurrent2021 — presentBoston, Massachusetts, United States
- MerckPartner, MRL Ventures Fund2018 — 2021Boston
- Myoventive, Inc.Board Directorcurrent2025 — presentSan Francisco Bay Area
- InsamoBoard Observercurrent2024 — present
- InduProBoard Directorcurrent2022 — present
- Photys TherapeuticsBoard Observercurrent2021 — present
- Mozart Therapeutics, IncBoard Directorcurrent2020 — present
- Aktis OncologyBoard Observer2024 — 2026Boston
- Tallac TherapeuticsBoard Director2021 — 2025
- Therini Bio, Inc.Board Director2024 — 2025San Francisco
- Ambagon TherapeuticsBoard Director2020 — 2024
- Caraway Therapeutics, Inc.Board Director2021 — 2023
- Carisma TherapeuticsBoard Observer2018 — 2023
- LifeMine TherapeuticsBoard Observer2021 — 2023
- HotSpot Therapeutics, Inc.Board Observer2020 — 2022
- Xilio Therapeutics, Inc.Board Observer2021
- Xilio Therapeutics, Inc.Board Director2019 — 2021
- Imago BioSciences, Inc.Board Observer2018 — 2021
- Kymera TherapeuticsBoard Observer2018 — 2020
- Wellington PartnersPrincipal2016 — 2018London / Munich
- Entrepreneurs FundAssociate2011 — 2016London
- Novartis Venture FundIntern Analyst / Consultant2009 — 2011
- Private Biopharmaceutical CompaniesConsultant2009 — 2011
- University of OxfordPost Doctoral Fellow2007 — 2009
- University of GenevaDoctoral Student2000 — 2006
- BC Centre for Disease ControlResearch Assistant2000
Skills & more
Biotechnology15Biopharmaceuticals3Medical Devices5Life Sciences8Diagnostics1Healthcare1Venture Capital17Entrepreneurship11Valuation4Competitive Intelligence2Market Analysis2Due Diligence3
+10 more
LifesciencesMolecular BiologyMolecular CloningBiochemistryGeneticsCommercializationData AnalysisNeuroscienceR&DResearchLanguages English · French · Polish
From Peter's professional profile.
Investments
Per curated public sources.
Colleagues at MRL Ventures Fund
Dr. Amit N. Thakker
Africa Healthcare Adviser at Asia Africa Investment & Consulting (AAIC)
Jason Ruth
Partner at MRL Ventures Fund
Karin Kleinhans
Partner at MRL Ventures Fund
Melissa Danforth
General Counsel, Life Sciences at Bain Capital Life Sciences
Olga Danilchanka
Partner at MRL Ventures Fund
Priya Agrawal
MSD at i3 — Investing in Innovation Africa
Tao Fang
Senior Associate at MRL Ventures Fund
Frequently asked questions
- Who is Peter Dudek?
- Ph.D. and president and managing partner of MRL Ventures Fund, describing the fund as an institutional venture partner taking active board or observer roles.
- Where does Peter Dudek work?
- Peter Dudek is President and Managing Partner at MRL Ventures Fund and Board director at Ambagon Therapeutics and Board director at Xilio Therapeutics.
- What companies has Peter Dudek invested in?
- Investments tracked here include Carisma Therapeutics, Mozart Therapeutics, Xilio Therapeutics.
- Where did Peter Dudek go to school?
- Peter Dudek studied at University of Oxford (Technology Spin-out Management Programme); Saïd Business School, University of Oxford (Building a Business, Medical Innovation); University of Geneva (Doctor of Philosophy, Cell Biology).
Same school
Also attended Saïd Business School, University of Oxford467
Manuk HergnyanCo-Founder & Managing Partner at Granatus VenturesMike MoradiGeneral Partner at Cortado VenturesDaniel van der MerweSenior Director at JMI EquityConnor WhitingFinance Associate at Giant Ventures Global LlpBrendan BakerPartner at Rackhouse Venture Management LpMorgan GerlakPartner at TCV
+ 461 more
Also attended University of Geneva93
Massimo PrelzInvestor at DN CapitalChristoph FreiPartner, Head of Energy at Emerald Technology Ventures AgErich SieberFounding General Partner at PeakBridge VCDavid MarcusInvestor at FELIX CAPITALMichelle PiontekImpact & ESG Associate at AENUPatrik BrudererCFO at CV Labs
+ 87 more
Also attended The University of British Columbia559
Joan MirallesHead of Administration & Valuation at Inveready Technology Investment GroupRares CrisanInvestor at Notable CapitalMarianne WuVenture Partner at Congruent VenturesBrendan BakerPartner at Rackhouse Venture Management LpAli KashaniVenture Partner at Think+ Ventures Management, LlcNick FitzInvestor at Juniper Ventures Management, Llc
+ 553 more
Also attended Capilano University15
Daniel DuboisInvestor at Side Door VenturesAki SiebelinkOperations Team at Autotech VenturesSarah GowePlatform Operations Manager at Forum VenturesMichelle PavlikVice President, Communications at ForesightTracy GrovesChief Marketing Officer at eCapital CanadaRichard EgliManaging Partner at Emend Vision Fund
+ 9 more
Shared employers
Also worked at Insamo3
Also worked at LifeMine Therapeutics2
Also worked at Xilio Therapeutics, Inc.8
Dan LynchInvestor at GV (Google Ventures)Nessan BerminghamInvestor at Khosla VenturesAlex Badamchi-ZadehVice President at SV Health InvestorsKeno GutierrezGeneral Partner at BioGeneration VenturesUgur EskiocakFounder / EIR at 82VSTim ClacksonFounder at IDRx
+ 2 more
Also worked at Kymera Therapeutics8
Richard ChesworthInvestor at Third Rock VenturesJohn MaraganoreAdvisor at Oak HC/FTWei LiGeneral Partner at 6 Dimensions CapitalChristopher O'DonnellPartner at Pfizer Venture InvestmentsNello MainolfiFounder at Kymera TherapeuticsSharon TownsonPh.D., Chief Scientific Officer at Monte Rosa Therapeutics
+ 2 more